FIELD: medicine, medical equipment; applicable in compensation of liver malfunction. SUBSTANCE: biological artificial liver has a body with branch pipes for supply and discharge of biological fluid. The body is filled with homogeneous mixture of particles of neutral carrier made in the form of diffusion-permeable material and fragments of liver tissues. Tissue fragments and carrier particles are taken in quantitative ratio of 1:2-1:10 with a*a*b sizes, where a = 0.4-0.6 mm and b = 0.4-3 mm. EFFECT: improved biochemical blood quantient and survival rate in treatment of liver acute affection. 2 cl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425645C1 |
| METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425646C1 |
| METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425648C1 |
| METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425647C1 |
| CELL PRODUCT FOR TREATING AND CORRECTING HEPATIC IMPAIRMENT | 2012 |
|
RU2510833C1 |
| METHOD OF NORMALIZING BIOCHEMICAL BLOOD PARAMETERS IN PATIENTS WITH IRREVERSIBLE LIVER FAILURE | 2020 |
|
RU2797291C2 |
| MEDICINAL AGENT FOR TREATING HEPATIC FIBROSIS, METHOD FOR PRODUCTION THEREOF AND METHOD OF TREATING HEPATIC FIBROSIS | 2015 |
|
RU2615445C2 |
| METHOD FOR DETERMINING DNA OF NODULAR DERMATITIS VIRUS (LSDV) IN BIOLOGICAL MATERIAL OF ANIMALS BY PCR WITH ELECTROPHORETIC DETECTION OF AMPLIFICATION PRODUCTS IN AGAROSE GEL | 2019 |
|
RU2728660C1 |
| HEPATOPROTECTIVE PROBIOTIC AGENT | 2006 |
|
RU2310463C1 |
| METHOD OF CURING PATIENTS SUFFERING FROM HEPATIC INSUFFICIENCY | 0 |
|
SU1813453A1 |
